Caprico Biotechnologies, Inc. (CBI)

Caprico Biotechnologies, Inc. (CBI) was founded in 2013 by a group of experienced scientists with broad clinical and basic research experience in chemistry, molecular biology, and immunology. We are committed to providing a range of flow cytometry reagents and services in support of basic research, clinical research, and clinical diagnostic applications. Our mission is to be a trusted partner for developing high-quality flow cytometry reagent products that improve your operational efficiency. We are always seeking new ways to expand our network throughout the US and worldwide.